| Test |
In Range |
Out Of Range |
Units |
Reference |
| Panel 083824 |
| HIV 1/0/2 Abs-ICMA |
| HIV 1/0/2 Abs-Index |
< 1.00 |
|
|
< 1.00 |
| Index Value |
Specimen reactivity relative to the negative cutoff. |
| HIV 1/0/2 Abs, Qual |
non Reactive |
|
Non Reactive |
| |
| Prostate-Spcific Ag, Serum |
| Prostate-Specific Ag, Serum |
|
5 H |
ng/mL |
0 - 4 |
| Roche ECLIA methodology. |
| |
According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. |
| |
| HCV Ab w/Rflx to Verification |
| HCV Ab |
< 0.1 |
|
s/co ratio |
0.0 - 0.9 |
| Comment |
| |
Non reactive HCV antibody screen is consistent with no HCV infection, unless recent infection is suspected or other evidence exists to indicate HCV infection. |
| |
| RPR |
Non reactive |
|
Non reactive |